Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma

Authors

  • Penvadee Pattanaprichakul,

    1. Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
    2. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Search for more papers by this author
  • Michael T. Tetzlaff,

    1. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Search for more papers by this author
  • Whitney J. Lapolla,

    1. Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Search for more papers by this author
  • Carlos A. Torres-Cabala,

    1. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    2. Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Search for more papers by this author
  • Madeleine Duvic,

    1. Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Search for more papers by this author
  • Victor G. Prieto,

    1. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    2. Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Search for more papers by this author
  • Kenneth Y. Tsai,

    1. Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Search for more papers by this author
  • Jonathan L. Curry

    Corresponding author
    1. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    2. Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Search for more papers by this author

No abstract is available for this article.

Ancillary